Summary
The product THELOBSTER SEMAGLUTIDE PEN & DUAL CHAMBER CARTRIDGE, manufactured by THELOBSTER, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number LOB6, was submitted by THELOBSTER and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Semaglutide, with detected concentrations of 10.97 mg and 9.42 mg. The product’s purity was determined to be 98.952% and 98.386%, respectively.
The testing process began on 7 October 2024, with the sample received on 11 October 2024, and analysis completed on 16 October 2024. While the results confirm high purity, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: The Lobster
- Product Name: THELOBSTER SEMAGLUTIDE PEN & DUAL CHAMBER CARTRIDGE
- Active Ingredient: Semaglutide
- Batch Number: LOB6
- Expiration Date: Not provided
- Delivery Method: Viral Powder
Sample Acquisition and Testing
- Task Number: #50503
- Testing Ordered: 7 October 2024
- Sample Received: 11 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: The Lobster (Manufacturer)
- Analysis Paid For By: The Lobster (Manufacturer)
Testing Results
- Specification: Not explicitly stated
- Measured Concentration: 10.97 mg; 9.42 mg
- Purity: 98.952%; 98.386%
Verification Details
Verification URL: https://janoshik.com/tests/50503_M5BUB4ZI29NE
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the high purity of the tested product. However, since THELOBSTER both submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that THELOBSTER SEMAGLUTIDE PEN & DUAL CHAMBER CARTRIDGE contains Semaglutide at measured concentrations of 10.97 mg and 9.42 mg, with high purity levels of 98.952% and 98.386%. The findings indicate strong quality control, but independent verification through third-party testing remains advisable to ensure consistency across batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding peptide products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
